ALLEGRI, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.393
EU - Europa 355
AS - Asia 232
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.986
Nazione #
US - Stati Uniti d'America 1.389
SG - Singapore 95
IT - Italia 77
DE - Germania 71
UA - Ucraina 51
CN - Cina 48
SE - Svezia 37
RU - Federazione Russa 34
IN - India 27
TR - Turchia 26
IE - Irlanda 25
GB - Regno Unito 17
VN - Vietnam 14
BE - Belgio 12
IR - Iran 12
RO - Romania 9
NL - Olanda 8
HK - Hong Kong 6
FI - Finlandia 5
CA - Canada 4
AT - Austria 3
JP - Giappone 3
TG - Togo 3
FR - Francia 2
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
LT - Lituania 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
Totale 1.986
Città #
Fairfield 199
Chandler 133
Ashburn 131
Woodbridge 98
Seattle 87
Singapore 87
Wilmington 82
Houston 69
Cambridge 60
Ann Arbor 57
Boardman 48
Udine 32
Dearborn 30
Izmir 26
Jacksonville 26
Dublin 25
Munich 22
Columbus 20
Beijing 19
New York 19
Princeton 17
Redmond 17
Ogden 16
Dong Ket 14
Brussels 12
Pune 12
Timisoara 9
Des Moines 7
Norwalk 7
Codroipo 6
Hong Kong 6
San Diego 6
San Mateo 6
City of Westminster 5
Hangzhou 5
Trieste 5
Augusta 4
Cagliari 4
Dallas 4
Hyderabad 4
Latisana 4
Amsterdam 3
Ardabil 3
Curno 3
Falls Church 3
Grafing 3
Hefei 3
Helsinki 3
Leawood 3
Lomé 3
London 3
Monmouth Junction 3
Nanjing 3
Portici 3
Vienna 3
Cleveland 2
Clifton 2
Florence 2
Guangzhou 2
Mumbai 2
Nagaoka 2
Nuremberg 2
Phoenix 2
Preston 2
Sacramento 2
Shenzhen 2
Tavagnacco 2
Toronto 2
Wuhan 2
Zanjan 2
Belgrade 1
Castiglione d'Adda 1
Cormeilles-en-Parisis 1
Falkenstein 1
Fayetteville 1
Grottaglie 1
Harbin 1
Islamabad 1
Jinan 1
Kashan 1
Kunming 1
Lappeenranta 1
Lausanne 1
Los Angeles 1
Losser 1
Madinat an Nasr 1
Manchester 1
Montreal 1
Moscow 1
Nanchang 1
Napoli 1
New Delhi 1
Ottawa 1
Reana del Rojale 1
Sabz 1
Salzgitter 1
Santa Clara 1
Shenyang 1
Taizhou 1
Trento 1
Totale 1.542
Nome #
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 160
null 146
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 138
Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder 129
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 116
null 110
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 109
null 98
Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantation and Individuation of CYP3A5 Genotype 98
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 95
EFFETTI DELL’INIBIZIONE DELLA RNA BINDING PROTEIN HuR NEL TUMORE TIROIDEO 73
Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells 70
BAZ1B is a candidate gene responsible for hypothyroidism in Williams syndrome 66
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 66
Critical involvement of calcium-dependent cytosolic phospholipase A2α in aortic valve interstitial cell calcification 61
null 54
Longitudinal dynamics of circulating tumor cells and circulating tumor DNA for treatment monitoring in metastatic breast cancer 52
Chiral ruthenium complexes: synthesis and evaluation of their anticancer activity 49
Cationic carboxylate and thioacetate ruthenium(ii) complexes: Synthesis and cytotoxic activity against anaplastic thyroid cancer cells 44
A paternally inherited 1.4 kb deletion of the 11p15.5 imprinting center 2 is associated with a mild familial Silver–Russell syndrome phenotype 42
Effects of dihydrotanshinone I on proliferation and invasiveness of paclitaxel-resistant anaplastic thyroid cancer cells 41
Effects of nutraceuticals on anaplastic thyroid cancer cells 37
Anti-htert sirna-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 33
Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells 33
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 27
Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity 25
GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid Cancer Cell Lines through MYCN Downregulation 22
Role of m6A RNA Methylation in Thyroid Cancer Cell Lines 20
Dihydrotanshinone I exhibits antitumor effects via β-catenin downregulation in papillary thyroid cancer cell lines 18
Chromoanagenesis of chromosome 22 in a subject with obesity and borderline cognitive performance 18
A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases 17
Effects of HuR downregulation on anaplastic thyroid cancer cells 12
The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases 11
Longitudinal detection of somatic mutations in the saliva of head and neck squamous cell carcinoma–affected patients: a pilot study 11
The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells 10
Totale 2.111
Categoria #
all - tutte 8.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020292 0 0 0 0 0 0 108 55 63 35 14 17
2020/2021350 28 22 25 41 21 36 10 36 24 20 52 35
2021/2022257 30 21 11 9 9 11 14 6 6 30 86 24
2022/2023283 26 35 6 35 33 56 0 25 40 8 9 10
2023/2024207 12 4 2 1 35 49 3 20 23 8 22 28
2024/2025265 21 35 54 80 40 31 4 0 0 0 0 0
Totale 2.111